Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

LEVOCETIRIZINE DIHYDROCHLORIDE

LEVOCETIRIZINE DIHYDROCHLORIDE

Standard Dose
2.5MG/5ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: None (Tentative Approval)
Summary

Approval overview LEVOCETIRIZINE DIHYDROCHLORIDE is listed in Drugs@FDA under application 211528 (ANDA).

Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient LEVOCETIRIZINE DIHYDROCHLORIDE Form and strength SOLUTION;ORAL - 2.5MG/5ML Sponsor APOTEX INC Submission history Latest submission status date: 2018-11-02 00:00:00.

Structured Monograph

Clinical summary

Approval overview LEVOCETIRIZINE DIHYDROCHLORIDE is listed in Drugs@FDA under application 211528 (ANDA). Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient LEVOCETIRIZINE DIHYDROCHLORIDE Form and strength SOLUTION;ORAL - 2.5MG/5ML Sponsor APOTEX INC Submission history Latest submission status date: 2018-11-02 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: None (Tentative Approval)
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.